Loading clinical trials...
Loading clinical trials...
Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Conditions
Interventions
Trans Sodium Crocetinate
Placebo
Locations
1
United States
Pulmonary Associates, P.A.
Phoenix, Arizona, United States
Start Date
December 2, 2021
Primary Completion Date
May 25, 2022
Completion Date
May 27, 2022
Last Updated
August 10, 2022
NCT07484243
NCT06992661
NCT07077486
NCT05878717
NCT07300696
NCT06626438
Lead Sponsor
Diffusion Pharmaceuticals Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions